Key result
Risk stratification in orthopaedic surgery lacks a comprehensive tool for individual decision-making, though the Elixhauser Comorbidity Measure and Risk Stratification Index 3.0 appear promising.
Why the study?
Risk stratification in orthopaedic surgery is complex and no comprehensive risk-stratification tool currently exists for individual patient decision-making, requiring surgeons to understand available tools and limitations.
Effective risk stratification in orthopaedic surgery is complex but necessary for individual decision-making and population-level alternative payment models.
Complex risk stratification in orthopaedic surgery warrants caution against simplistic surgeon penalization; leaves open optimal predictive models.
➢ Risk stratification in orthopaedic surgery is complex and depends on the outcome of interest and multiple interdependent factors. Effective risk stratification has uses for limiting and predicting adverse events in patients undergoing discretionary surgery, avoiding the penalization of surgeons for operating on candidates whose health is situated in more difficult circumstances, and ensuring that inordinate attention is not placed on discrete musculoskeletal pathophysiology when there are other pressing health priorities.➢ For individual patient decision-making, no comprehensive risk-stratification tool currently exists, in part due to the heterogeneity of orthopaedic procedures performed and the diverse patient population treated. The Elixhauser Comorbidity Measure and the Risk Stratification Index 3.0 appear to be most promising.➢ At a population level, risk stratification may be useful in alternative payment models to ensure that hospitals that treat a disproportionate number of high-risk patients are not penalized and that cherry-picking (preferentially selecting only healthier patients with a lower risk of complications) does not occur. Any attempt to risk-stratify may have unintended consequences.➢ Orthopaedic surgeons must be aware of the tools available, their strengths, and their limitations in order to be included in decision-making as payment models and public health policies are implemented.
No takes yet. Share an insight, caveat, or question.
Boyle et al. (2025) conducted a review in Orthopaedic surgery. Risk stratification tools was evaluated. Risk stratification in orthopaedic surgery lacks a comprehensive tool for individual decision-making, though the Elixhauser Comorbidity Measure and Risk Stratification Index 3.0 appear promising.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: